Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rami Hershkowitz"'
Autor:
Katerina Shulman, Ilana Weiss, Matitiahu Berkovitch, Shai Ashkenazi, Moshe E Gatt, Osnat Luxenburg, Stephany Hiayev, Einat Shacham-Shmueli, Michal Hirsch Vexberg, Rami Hershkowitz, Einat Gorelik, Haim Mayan, Yehudit Steinmetz, Noa Berar Yanai, Orly Schlissel, Muhammad Azem, Neriya Gutgold, Milly Divinsky, Nirit Yarom, Alla Vishkautzan, Chezi Ganzel, Lidia Arcavi, Eli Marom, Biatrice Uziely, Shoshana Zevin, Hadar Meirow, Denize Ainbinder
Publikováno v:
BMJ Open, Vol 13, Iss 5 (2023)
Objectives US FDA and EMA allow facilitated regulatory pathways to expedite access to new treatments. Limited supportive data may result in major postapproval variations. In Israel, partly relying on Food and Drug Administration (FDA) and European Me
Externí odkaz:
https://doaj.org/article/5182d1f30202403fba42ed308f75acff
Autor:
Stephany Hiayev, Einat Shacham-Shmueli, Matitiahu Berkovitch, Ilana Weiss, Shai Ashkenazi, Michal Hirsch Vexberg, Rami Hershkowitz, Einat Gorelik, Haim Mayan, Yehudit Steinmetz, Noa Berar Yanai, Orly Schlissel, Muhammad Azem, Neriya Gutgold, Katerina Shulman, Milly Divinsky, Nirit Yarom, Alla Vishkautzan, Chezi Ganzel, Moshe E Gatt, Lidia Arcavi, Eli Marom, Biatrice Uziely, Shoshana Zevin, Hadar Meirow, Osnat Luxenburg, Denize Ainbinder
Publikováno v:
BMJ Open. 13:e067313
ObjectivesUS FDA and EMA allow facilitated regulatory pathways to expedite access to new treatments. Limited supportive data may result in major postapproval variations. In Israel, partly relying on Food and Drug Administration (FDA) and European Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b3cb3a6968b11d5f73e64f6d200cb1f
https://doi.org/10.1136/bmjopen-2022-067313
https://doi.org/10.1136/bmjopen-2022-067313